Cargando…
Correction to: Satralizumab: First Approval
Autor principal: | Heo, Young-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522103/ https://www.ncbi.nlm.nih.gov/pubmed/32902801 http://dx.doi.org/10.1007/s40265-020-01391-z |
Ejemplares similares
-
Satralizumab: First Approval
por: Heo, Young-A
Publicado: (2020) -
Correction to: Efgartigimod: First Approval
por: Heo, Young-A
Publicado: (2022) -
Correction to: Revefenacin: First Global Approval
por: Heo, Young-A
Publicado: (2019) -
Correction to: Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018) -
Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)